Boosting anti-HIV immunity with pomalidomide
In a recent study, researchers at the University of Melbourne used the immune-enhancing drug, pomalidomide, to boost immunity against HIV.
Novel approaches
In a quickly developing area such as HIV cure research, many studies use strategies that don’t fit into the standard categories. Here you will find details of studies that are one of a kind, or which take a strategy from a different field of study and apply it to HIV cure.
Broadly neutralizing antibodies (bNABs) as a component of an HIV cure: results from the TITAN study
Drs Jesper D. Gunst PhD, Thomas A. Rasmussen PhD and Ole S. Søgaard PhD of Aarhus University Hospital, Denmark share
Licence to Kill: Pro-apoptotic drugs in “Shock and Kill” HIV cure approach
A cure to HIV remains elusive. HIV-infected cells survive in the body by avoiding the usual ways the immune system
Block and lock: a pathway to remission
‘Block and lock’ is an emerging option in the pursuit of an HIV cure. Kirby Institute researchers have developed an
The promise and challenge of stem cell transplants in HIV cure
The only confirmed case of HIV cure, and two cases of long-term remission without treatment, are the result of stem
Joining the search for a cure
This article was originally published in the Spring 2018 issue of Poslink, the newsletter of Living Positive Victoria. Have you
What’s the fuss about a functional cure?
A recent study from researchers in Hong Kong has got the world’s media talking about a functional cure for HIV. A
VIVA trial: Vitamin D in HIV latency
The current standard treatment for people living with HIV is a combination of drugs known as antiretroviral therapy (or ART).
Gut feeling for a functional cure
HIV infection takes a heavy toll on the gut. The virus enters the body and heads straight for the stomach
Searching for hidden HIV
Attempts to cure HIV have been thwarted by a particular type of immune-system cell that can hide the virus. These
Locking in HIV – can silencing lead to cure?
During primary infection, HIV naturally establishes latency in specialised immune cells, mainly CD4 T cells. A research group led by
Engineered T cells show promise in fight against HIV
T cells that target HIV but are resistant to HIV infection are the latest strategy in the battle against HIV.